Drug recall · February 11, 2026
Trazodone Hydrochloride recall
Why: Presence of Foreign Tablets/Capsules
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granules India Limited, Hyderabad, 500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-231-01.
- Lots / codes
Batch # 6160008A, Exp Date: 12/31/2026
- Quantity
- 71424 bottles.
- Company
- Granules Pharmaceuticals Inc., Chantilly, VA
- Distribution
- US Nationwide.
- Initiated
- January 26, 2026 · Voluntary: Firm initiated
- Classified
- February 11, 2026
- Reported
- February 11, 2026
- How notified
- N/A
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Trazodone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.